Pfizer Comes Up SHORT and 4 HOT Stocks Making Headlines

Japanese insurer Dai-ichi Life plans to acquire at least 15% up to a maximum of 20%, of Janus Group’s (NYSE:JNS) outstanding common shares through open market purchases and potentially through the exercise of conditional options issued to Dai-ichi Life by JNS; further, Dai-ichi will support JNS’ distribution initiatives in Japan and plans to invest USD$2 billion of its general account assets with JNS.

Don’t Miss: Wall Street Brief: Yahoo May END Buyback Program, Chesapeake in Trouble, J.C. Penney Down 9%.

Pfizer‘s (NYSE:PFE) Phase 3 study of Torisel, aimed at patients suffering from advanced renal cell carcinoma, failed to come up to company benchmarks that ensured progression-free survival.

Nike’s (NYSE:NKE) Cole Haan unit, a maker of handbags and shoes, is on the block and seeing hectic bidding that may drive the sale price to $500 million; P-E firms TPG Capital Management and Apax Partners are reportedly in the fray.

Chinese oil company Cnooc’s (NYSE:CEO) proposed $15B buyout of Canadian oil producer Nexen (NYSE:NXY) has already drawn the criticism of U.S. lawmakers as a potential security risk; Cnooc nevertheless proposes to request a national security review from the U.S., saying it is a publicly traded company that has a good record of compliance with U.S. law.

Don’t Miss: Here’s How Facebook Plans to FIX Its Ad Strategy.